Supreme Court Urged To Revive OxyContin Patents
Purdue Pharma LP and Grunenthal GmbH have urged the U.S. Supreme Court in separate filings to reverse the Federal Circuit's nixing of the asserted claims of four patents related to the...To view the full article, register now.
Already a subscriber? Click here to view full article